Thomas Bethge / shutterstock.com
14 October 2016Big PharmaBernd Allekotte and Franz Zimmer
Pay-for-delay: Play by the rules
On September 8, the EU General Court handed down its judgment in appeal proceedings brought by Danish innovator Lundbeck and a number of generic companies against a 2013 European Commission decision that imposed fines of €146 million ($164 million) on the appellants.
